Can a blood protein predict metabolic changes after gastric bypass?

NCT ID NCT07774208

First seen Aug 19, 2026 ยท Last updated Aug 19, 2026

Summary

This study looks at how a protein called FABP4, which is linked to fat metabolism, changes in the blood after Roux-en-Y gastric bypass surgery. Researchers are following 28 adults who had the surgery, measuring FABP4 levels along with weight, body composition, inflammation, and gut hormones at 3 and 6 months. The goal is to see if different patterns of FABP4 change are related to the amount of weight loss or other metabolic improvements. This is an observational study, so it does not test a treatment but aims to better understand the body's response to surgery.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If this study succeeds, it could help explain why some people have different metabolic responses after gastric bypass, potentially guiding more personalized follow-up care.
What could go wrong
This is a small, retrospective observational study, so it cannot prove cause and effect. The findings may not apply to everyone and need confirmation in larger, prospective studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BARIATRIC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Inflammation Insulin Resistance Obesity obesity disorder Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.